Calvary Consortium Secures Healthscope, Whyalla Faces Job Cuts

Company News

by Finance News Network


Australian shares saw a modest uplift around noon AEST, propelled by a spike in oil prices that boosted the energy sector. This positive market sentiment unfolded amidst significant corporate developments, notably the successful acquisition of Healthscope by a consortium led by Calvary Health Care. The deal concludes 16 months of uncertainty for Healthscope, Australia’s second-largest hospital operator. However, the corporate landscape also presented grim news from Whyalla, where the failed restart of its blast furnace will result in more than 500 job redundancies. Administrator KordaMentha confirmed the critical section of the steelworks is irreparable, leading to job cuts for over half of the 1,100 workers.

Meanwhile, the rapidly evolving artificial intelligence sector continues to be a focal point of discussion regarding regulation and safety. Leading AI firms, including OpenAI, Anthropic, and SpaceX, are in unusual agreement about the need to slow AI development due to escalating safety concerns. OpenAI’s global policy head highlighted that governments are struggling to keep pace with AI’s swift advancements, compelling companies to adopt voluntary standards. This sentiment was echoed by concerns from tech executives, despite former US President Trump rejecting calls for an AI slowdown in the race for global dominance against China.

In other market news, GenusPlus secured a substantial $160 million battery contract, contributing to the day’s corporate activity, while FleetPartners experienced a share jump following sweetened offers. On the leadership front, Mark Cutifani’s resignation from the Woodside board, to join Northern Star, has disrupted the energy giant’s succession planning for Richard Goyder. The Sydney property market also reflected challenging conditions, with a $4.8 million sale leaving a vendor out of pocket, a scenario increasingly common as the market reverts to 2023 price levels.


Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?